Publishing research using ab9695? Please let us know so that we can cite the reference in this datasheet.

ab9695 has been referenced in 7 publications.

  • Zhang X  et al. Hypoxia-inducible factor-1a mediates the toll-like receptor 4 signaling pathway leading to anti-tumor effects in human hepatocellular carcinoma cells under hypoxic conditions. Oncol Lett 12:1034-1040 (2016). WB ; Human . PubMed: 27446390
  • Guo Z  et al. Differential urinary glycoproteome analysis of type 2 diabetic nephropathy using 2D-LC-MS/MS and iTRAQ quantification. J Transl Med 13:371 (2015). WB . PubMed: 26608305
  • Alvarez LM  et al. Tethering of Epidermal Growth Factor (EGF) to Beta Tricalcium Phosphate (ßTCP) via Fusion to a High Affinity, Multimeric ßTCP-Binding Peptide: Effects on Human Multipotent Stromal Cells/Connective Tissue Progenitors. PLoS One 10:e0129600 (2015). PubMed: 26121597
  • Prasse AA  et al. Improvement of an antibody-enzyme coupling yield by enzyme surface supercharging. BMC Biotechnol 14:88 (2014). PubMed: 25326050
  • Bracher A  et al. Epidermal growth factor facilitates melanoma lymph node metastasis by influencing tumor lymphangiogenesis. J Invest Dermatol 133:230-8 (2013). PubMed: 22951723
  • Mechaly A  et al. Changing the receptor specificity of anthrax toxin. MBio 3:N/A (2012). PubMed: 22550037
  • Kumagai K  et al. Up-regulation of EGF receptor and its ligands, AREG, EREG, and HB-EGF in oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 110:748-54 (2010). IHC-P ; Human . PubMed: 20952227

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up